Showing 1,101 - 1,120 results of 22,046 for search '(( 5 ((step decrease) OR (nn decrease)) ) OR ( 100 ((mean decrease) OR (a decrease)) ))', query time: 0.93s Refine Results
  1. 1101
  2. 1102

    S100A9 is a Biliary Protein Marker of Disease Activity in Primary Sclerosing Cholangitis by Lisa Reinhard (188324)

    Published 2012
    “…In PSC patients, the biliary S100A9 expression was elevated 95-fold (p<0.005), serum protein expression was decreased, and pancreatic enzyme expression was unchanged compared to controls. …”
  3. 1103
  4. 1104
  5. 1105

    Rabbit ATG and alemtuzumab decrease effector mechanisms of peripheral blood CD3<sup>−</sup>CD56<sup>dim</sup> NK cells. by Diana Stauch (266579)

    Published 2009
    “…<p>(A) Dose-dependent decrease of NK cell cytotoxicity after 18 hours pretreatment with rATG, alemtuzumab, daclizumab and rIgG (0–100 µg). …”
  6. 1106
  7. 1107

    S1 Data - by Timmion K. Skervin (11432568)

    Published 2021
    Subjects:
  8. 1108
  9. 1109
  10. 1110
  11. 1111
  12. 1112
  13. 1113

    Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations. by Denis Mustafov (19137870)

    Published 2025
    “…<p><b>(A)</b> A significant reduction in colony-forming ability was observed in U87MG cells treated with 100ΜM SHG-44 compared to 100ΜM cis-platin and the untreated control. …”
  14. 1114
  15. 1115

    Supplementary Material for: Serum Concentration and Skin Expression of S100A7 (Psoriasin) in Patients Suffering from Hidradenitis Suppurativa by Batycka-Baran A. (9650738)

    Published 2020
    “…The serum concentration of S100A7 in individuals with HS was decreased as compared to healthy controls and patients with psoriasis. …”
  16. 1116
  17. 1117

    Fig 5 - by Frank Rattay (127304)

    Published 2022
    Subjects:
  18. 1118
  19. 1119

    The prevalence of hypertension, diabetes, metabolic syndrome, cardiovascular disease and decreased GFR according to the following age groups: 60–69, 70–79 and ≥80 years. by Regina C. R. M. Abdulkader (302450)

    Published 2017
    “…Metabolic syndrome: presence of at least three of the following criteria: a waist circumference ≥90 cm for men or ≥80 cm for women, triglycerides ≥150 mg/dL, an HDL cholesterol ≤40 mg/dL for males or ≤50 mg/dL for females, a systolic blood pressure ≥130 mm Hg or a diastolic blood pressure ≥85 mmHg and a fasting plasma glucose ≥100 mg/dL. …”
  20. 1120